Skip to content

Clinical study of different methods in the treatment of recurrent corneal epithelial erosion

Clinical study of different methods in the treatment of recurrent corneal epithelial erosion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102498
Enrollment
Unknown
Registered
2025-05-15
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent corneal erosion

Interventions

Epithelial debridement group:None
PTK group 1:None
PRK group 1:None
PTK group 2:None
PRK group 2:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria of recurrent corneal epithelial erosion. According to the following diagnostic criteria: a more than one attack of the same corneal epithelial defect without obvious inducement; b had a definite history of minor corneal trauma; c morning eye surface pain recurred; d Grayish white or rough surface lesions were found in some areas of the corneal epithelium. If condition a is met and one of conditions b-d is met, diagnosis can be made. 2.No previous surgical treatment was used; 3.Age >= 18 years old; 4.Agree to enter this study;

Exclusion criteria

Exclusion criteria: 1.Patients with a history of eye surgery; 2.Exclude eyelid structural abnormalities such as valgus, trichiasis and eyelid dysclosure; Infectious conjunctivitis or keratitis, glaucoma, thyroid related eye diseases, etc; 3.Serious primary diseases of cardiovascular, cerebrovascular, liver, kidney, endocrine and hematopoietic system, etc. Connective tissue diseases and severe autoimmune diseases, such as rheumatoid arthritis, sarcoidosis, lupus erythematosus, thyroiditis, etc.; Malignant tumor patients, etc. 4.Patients with scar constitution, patients with history of mental injury disorders, patients with intelligence defects, cognitive dysfunction, etc; 5.The treatment of drugs, anesthetic drugs, bandage mirror allergy; 6.Patients with contraindications to excimer laser surgery; 7.Do not agree to enter this study;

Design outcomes

Primary

MeasureTime frame
Recovery time of healthy epithelium;Postoperative recurrence rate;

Secondary

MeasureTime frame
Corneal epithelial thickness;Postoperative irritation symptoms;

Countries

China

Contacts

Public ContactWu Shuangqing

Eye Hospital, Wenzhou Medical University

shuangqingwu@yahoo.com.cn+86 571 8818 5666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026